Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  SBI Holdings Inc    8473   JP3436120004

SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

SBI Holdings, Inc. : Basic Agreement Reached with the Bahrain Development Bank for Promoting 5-ALA Business in Bahrain

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/21/2013 | 07:53am CEST

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in

reliance upon the whole or any part of the contents of this announcement.

SBI HOLDINGS, INC.

(Incorporated in Japan with limited liability)

(Stock code: 6488) OVERSEAS REGULATORY ANNOUNCEMENT

This announcement is made pursuant to Rule 13.10B of the Rules Governing the Listing of Securities on The
Stock Exchange of Hong Kong Limited.

Please refer to the attached copy of the Announcement.

On behalf of the Board SBI Holdings, Inc. Yoshitaka Kitao Representative Director,

President & Chief Executive Officer

Japan, 21 March 2013

As of the date of this announcement, the executive Directors are Mr Yoshitaka Kitao, Mr Taro Izuchi, Mr Takashi Nakagawa, Mr Tomoya Asakura, Mr Shumpei Morita, Mr Noriaki Maruyama and Mr Peilung Li, the non-executive Directors are Mr Hiroyoshi Kido, Mr Noriyoshi Kimura, Mr Hiroshi Tasaka and Mr Takashi Okita and the independent non-executive Directors are Mr Masaki Yoshida, Mr Kiyoshi Nagano, Mr Keiji Watanabe, Mr Akihiro Tamaki and Mr Masanao Marumono.

21 March 2013
SBI Holdings, Inc. (TOKYO: 8473 / Hong Kong: 6488)

Basic Agreement Reached with the Bahrain Development Bank for Promoting 5-ALA Business in Bahrain

We are pleased to inform you that SBI Pharmaceuticals Co., Ltd. (Head office: Minato-ku, Tokyo;
Representative Director and CEO: Yoshitaka Kitao; "SBI Pharmaceuticals"), a subsidiary of SBI Holdings, Inc., engaged in research and development of pharmaceuticals, health foods and cosmetics using 5-aminolevulinic acid (5-ALA) (*1), has reached a basic agreement to cooperate in promoting the 5-ALA business in Bahrain
with the Bahrain Development Bank (Location: Manama, Bahrain; Representative: Shaikh Mohammed Bin Essa Bin Mohammed Al Khalifa) that is engaged in providing business support to small- and medium-sized companies under the umbrella of the Bahrain government.
The Bahrain Development Bank is a governmental financial institution in Bahrain and was established in 1992 for promoting the business projects of small- and medium-sized companies in Bahrain.
SBI Pharmaceuticals is currently working with various partners, including local universities, research institutions and private companies, as it prepares for the research and development of pharmaceuticals which use 5-ALA and for manufacturing and selling 5-ALA related products; and it will promote the research and development as well as the manufacturing and sales of pharmaceuticals which use 5-ALA, while relying on local legal and financial advice and support from the Bahrain Development Bank. SBI Pharmaceuticals is hoping to further accelerate the expansion of its 5-ALA business in Bahrain, with the cooperation of the Bahrain Development Bank obtained by this basic agreement.
SBI Pharmaceuticals will continue to cooperate closely with the Bahrain government in promoting the business, while pursuing various possibilities of 5-ALA in order to contribute to the health of as many people in the
world as possible, and will make every effort to work on research and development as well as on spreading
5-ALA related products with partners both inside and outside Japan.

(*1) 5-aminolevulinic acid (5-ALA): An amino acid created in mitochondria. It is an important substance that serves as protein material related to energy production in the form of hemes and cytochromes, and its productivity is known to decrease with age. 5-ALA is contained in shochu distillation remnants, red wine and food such as radish sprouts. It is also known as a material forming chloroplasts in plants.

**************************************************************************************** For further information, please contact:
SBI Holdings, Inc.: Corporate Communications Dept., Tel: +81 3 6229 0126
SBI Pharmaceuticals Co., Ltd.: Corporate Planning Dept., Tel: +81 3 6229 0095

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SBI HOLDINGS INC
05/26 SBI : Notice of Memorandum of Understanding on Establishing of a Joint Venture L..
05/24 SBI : Notice Regarding an Investment into R3 HOLDCO LLC, a U.S. FinTech Company ..
04/28 SBI : Notice regarding Adjustment of Conversion Price for 30,000,000,000 Zero Co..
04/18 SBI : Annual Results Announcement for the Fiscal Year Ended March 31, 2017 of SB..
03/29 SBI HOLDINGS INC : ex-dividend day for final dividend
03/15 SBI Pharma and Chugai Enter an Agreement ofExclusive Marketing Rights for 'AL..
03/15 SBI : Notice Regarding an Investment into solarisBank AG entry(2017 ,3 , 15)
03/14 SBI : Revision of Dividend Forecast for the Fiscal Year Ending March 31, 2017 en..
03/09 SBI : Notice Regarding an Investment into Veem Inc. entry(2017 ,3 , 9)
03/07 SBI : Notice Regarding an Investment into Episode Six Limited entry(2017 ,3 , 3)
More news
Sector news : Diversified Investment Services
05/26DJCITIC : Says It Plans to Spin Off Unit Citic Press on Shenzhen Stock Exchange's ..
05/18 South Africa's Investec to expand into life insurance
05/12DJNew South Wales Seeks Buyer for WestConnex Toll Road
05/11DJMACQUARIE : Consortium Lands Lease for New South Wales's Power Utility
05/10DJAustralia Banks Warn of Cost of New Levy
More sector news : Diversified Investment Services
Advertisement
Financials ( JPY)
Sales 2018 277 800 M
EBIT 2018 -
Net income 2018 28 208 M
Debt 2018 -
Yield 2018 2,66%
P/E ratio 2018 10,68
P/E ratio 2019 10,61
Capi. / Sales 2018 1,17x
Capi. / Sales 2019 1,05x
Capitalization 325 165 M
More Financials
Chart SBI HOLDINGS INC
Duration : Period :
SBI Holdings Inc Technical Analysis Chart | 8473 | JP3436120004 | 4-Traders
Full-screen chart
Technical analysis trends SBI HOLDINGS INC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 1 270  JPY
Spread / Average Target -12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Yoshitaka Kitao President & Representative Director
Tomoya Asakura Director & Senior Managing Executive Officer
Shumpei Morita Director & Managing Executive Officer
Kiyoshi Nagano Independent Outside Director
Keiji Watanabe Outside Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SBI HOLDINGS INC-2.75%2 919
CITIC LTD10.27%45 699
MACQUARIE GROUP LTD1.93%22 505
NATIXIS20.80%21 464
CHINA HUARONG ASSET MA..13.62%15 896
INVESTEC PLC16.23%7 927
More Results